Additive Value of Biomarkers and Echocardiography to Stratify the Risk of Death in Heart Failure Patients with Reduced Ejection Fraction.

Calogero FallettaFrancesco ClemenzaCatherine KlersyValentina AgneseDiego BellaviaGabriele Di GesaroChiara MinàGiuseppe RomanoPier Luigi TemporelliFrank Lloyd DiniAndrea RossiClaudia RaineriAnnalisa TurcoEgidio TraversiStefano Ghio

Published in: Cardiology research and practice (2019)

In a HFrEF outpatient cohort, the evaluation of plasma levels of both NPs and hsTnI can contribute significantly to identifying patients who have a worse prognosis, in addition to the echocardiographic assessment of right ventricular-arterial coupling.

Keyphrases

heart failure
left ventricular
ejection fraction
end stage renal disease
pulmonary hypertension
newly diagnosed
chronic kidney disease
computed tomography
peritoneal dialysis
atrial fibrillation
mitral valve
room temperature
cardiac resynchronization therapy
patient reported